Cargando…

Systematic Review on Infusion Reactions Associated with Chemotherapies and Monoclonal Antibodies for Metastatic Colorectal Cancer

OBJECTIVE: The objective of this systematic review is to summarize the literature to date on the rates of infusion reactions (IR) associated with chemotherapies and monoclonal antibody (mAb) drug therapies used for the treatment of metastatic colorectal cancer (mCRC) and the associated clinical and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Xue, Long, Stacey R, Barber, Beth, Kassed, Cheryl A, Healey, Marcus, Jones, Clare, Zhao, Zhongyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363055/ https://www.ncbi.nlm.nih.gov/pubmed/22299770 http://dx.doi.org/10.2174/157488412799218806

Ejemplares similares

Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis
por: Ma, Qiufei, et al.
Publicado: (2016)

Comorbid Conditions in Patients With Metastatic Colorectal Cancer
por: Fu, Alex Z, et al.
Publicado: (2011)

Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab
por: Odom, Dawn, et al.
Publicado: (2010)

Clinical development methodology for infusion-related reactions with monoclonal antibodies
por: Doessegger, Lucette, et al.
Publicado: (2015)

The importance of early identification of infusion-related reactions to monoclonal antibodies
por: Cáceres, Macarena C, et al.
Publicado: (2019)

Acute low back pain as infusion-related reaction to monoclonal antibodies
por: Majenka, Pawel, et al.
Publicado: (2023)

Major Surgery in Patients with Metastatic Colorectal Cancer in Western Europe
por: Zhao, Zhongyun, et al.
Publicado: (2011)

Effect of RAS status on anti-EGFR monoclonal antibodies + 5-FU infusion-based chemotherapy in first-line treatment of metastatic colorectal cancer: A meta-analysis
por: Zhou, Mingyi, et al.
Publicado: (2016)

Evaluating the treatment of metastatic colorectal cancer with monoclonal antibodies
por: Popa, C, et al.
Publicado: (2012)

Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer patients: is efficacy maintained?
por: Grande, Roberta, et al.
Publicado: (2013)

Treatment Patterns in Patients with Metastatic Melanoma: A Retrospective Analysis
por: Zhao, Zhongyun, et al.
Publicado: (2014)

Rapid desensitization in delayed hypersensitivity reactions to chemotherapy and monoclonal antibodies
por: Vega, Arantza, et al.
Publicado: (2014)

Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal Cancer
por: Randrian, Violaine, et al.
Publicado: (2022)

Clinical and economic impact of infusion reactions in patients with colorectal cancer treated with cetuximab
por: Foley, K. A., et al.
Publicado: (2010)

Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer
por: Fakih, M., et al.
Publicado: (2010)

Delivering Monoclonal Antibody Infusions to Novel Outpatient Settings
por: Minnich, Amy, et al.
Publicado: (2022)

Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion
por: Goldin, Laurel, et al.
Publicado: (2021)

Economic burden of toxicities associated with treating metastatic melanoma in eight countries
por: Wehler, Elizabeth, et al.
Publicado: (2015)

Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer
por: Goi, Takanori, et al.
Publicado: (2015)

The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta‐analysis of patient and study characteristics
por: Bylsma, Lauren C., et al.
Publicado: (2019)

Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies
por: Vega, Arantza, et al.
Publicado: (2022)

Infusion Reactions Associated with the Medical Application of Monoclonal Antibodies: The Role of Complement Activation and Possibility of Inhibition by Factor H
por: Fülöp, Tamás, et al.
Publicado: (2018)

Use of perioperative chemotherapy in colorectal cancer metastatic to the liver
por: Symonds, Lynn K, et al.
Publicado: (2019)

Monoclonal antibodies to human colon and colorectal carcinoma.
por: Thompson, C. H., et al.
Publicado: (1983)

Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data
por: Ma, Qiufei, et al.
Publicado: (2018)

Indirect Treatment Comparison of Talimogene Laherparepvec Compared with Ipilimumab and Vemurafenib for the Treatment of Patients with Metastatic Melanoma
por: Quinn, Casey, et al.
Publicado: (2016)

Hypersensitivity Reactions to Monoclonal Antibodies in Children
por: Mori, Francesca, et al.
Publicado: (2020)

Acute bilateral angle closure induced by monoclonal antibody (Daratumumab) infusion
por: Saengsirinavin, Aim-on, et al.
Publicado: (2021)

Monoclonal Antibody Infusion Service for Obstetric Women Infected With COVID-19
por: Hiner, Jacqueline B., et al.
Publicado: (2022)

Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
por: da Silva, Wânia Cristina, et al.
Publicado: (2018)

Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison
por: Quinn, Casey, et al.
Publicado: (2016)

Radiolabelled monoclonal antibodies in the treatment of metastatic cancer
por: Goldenberg, D.M.
Publicado: (2007)

Effectiveness and safety of monoclonal antibodies for metastatic colorectal cancer treatment: systematic review and meta-analysis
por: Rosa, Bruno, et al.
Publicado: (2015)

Allergic diseases of the skin and drug allergies – 2017. Rapid desensitization for delayed reactions to chemotherapy and monoclonal antibodies
por: Vega Castro, Maria Aranzazu, et al.
Publicado: (2013)

Monoclonal antibody infusion reaction with bamlanivimab and etesevimab in a 5-year-old male with coronavirus disease 2019: a case report
por: Pillai, Rajapillai L. I., et al.
Publicado: (2023)

Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
por: Mao, C, et al.
Publicado: (2010)

CEA dynamics for predicting response after anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
por: Kang, Sora, et al.
Publicado: (2023)

Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy
por: Zhang, Hang-Yu, et al.
Publicado: (2018)

Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody.
por: Smedley, H. M., et al.
Publicado: (1983)

Eptinezumab: A calcitonin gene-related peptide monoclonal antibody infusion for migraine prevention
por: Morgan, Kelsey Woods, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ppiu4hmohbp4rpmjtffg2au5ji